Action to address the household economic burden of non-communicable diseases

The Lancet

Volumn 391, Issue 10134, 2018, Pages 2047-2058

  Jan, Stephen ^a,b   Laba, Tracey Lea ^a,b   Essue, Beverley M ^a,b   Gheorghe, Adrian ^c   Muhunthan, Janani ^a,b   Engelgau, Michael ^d   Mahal, Ajay ^e   Griffiths, Ulla ^c   McIntyre, Diane ^f   Meng, Qingyue ^g   Nugent, Rachel ^h   Atun, Rifat ⁱ  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f UNIVERSITY OF CAPE TOWN   (South Africa)

^g PEKING UNIVERSITY   (China)

^h RTI INTERNATIONAL   (United States)

ⁱ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH INSURANCE; HOUSEHOLD ECONOMIC STATUS; HUMAN; INCIDENCE; LOW INCOME COUNTRY; MEDICATION COMPLIANCE; MIDDLE INCOME COUNTRY; NON COMMUNICABLE DISEASE; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; SCALE UP; ECONOMICS; FAMILY SIZE; MEDICALLY UNINSURED; PUBLIC HEALTH; STATISTICS AND NUMERICAL DATA;

FAMILY CHARACTERISTICS; FINANCING, PERSONAL; HEALTH EXPENDITURES; HUMANS; INSURANCE, HEALTH; MEDICALLY UNINSURED; NATIONAL HEALTH PROGRAMS; NONCOMMUNICABLE DISEASES;

EID: 85044869983     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(18)30323-4     Document Type: Review

References (116)

1. Mendis, S, Global status report on noncommunicable diseases 2014. 2014, World Health Organization, Geneva.
2. Hynd, A, Roughead, EE, Preen, DB, Glover, J, Bulsara, M, Semmens, J, The impact of co-payment increases on dispensings of government-subsidised medicines in Australia. Pharmacoepidemiol Drug Saf 17 (2008), 1091–1099.
3. Lexchin, J, Grootendorst, P, Effects of prescription drug user fees on drug and health services use and on health status in vulnerable populations: a systematic review of the evidence. Int J Health Serv 34 (2004), 101–122.
4. Tamblyn, R, Laprise, R, Hanley, JA, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA 285 (2001), 421–429.
5. Arora, RS, Eden, T, Pizer, B, The problem of treatment abandonment in children from developing countries with cancer. Pediatr Blood Cancer 49 (2007), 941–946.
6. Israels, T, Chirambo, C, Caron, H, de Kraker, J, Molyneux, E, Reis, R, The guardians' perspective on paediatric cancer treatment in Malawi and factors affecting adherence. Pediatr Blood Cancer 51 (2008), 639–642.
7. Jan, S, Kimman, M, Peters, SAE, Woodward, M, Financial catastrophe, treatment discontinuation and death associated with surgically operable cancer in south-east Asia: results from the ACTION Study. Surgery (United States) 157 (2015), 971–982.
8. Hanratty, B, Holland, P, Jacoby, A, Whitehead, M, Financial stress and strain associated with terminal cancer—a review of the evidence. Palliat Med 21 (2007), 595–607.
9. Alam, K, Mahal, A, Economic impacts of health shocks on households in low and middle income countries: a review of the literature. Global Health, 10, 2014, 21.
10. McIntyre, D, Thiede, M, Dahlgren, G, Whitehead, M, What are the economic consequences for households of illness and of paying for health care in low- and middle-income country contexts?. Soc Sci Med 62 (2006), 858–865.
11. Engelgau, MM, Karan, A, Mahal, A, The economic impact of non-communicable Diseases on households in India. Global Health, 8, 2012, 9.
12. Smith-Spangler, CM, Bhattacharya, J, Goldhaber-Fiebert, JD, Diabetes, its treatment, and catastrophic medical spending in 35 developing countries. Diabetes Care 35 (2012), 319–326.
13. Huffman, MD, Rao, KD, Pichon-Riviere, A, et al. A cross-sectional study of the microeconomic impact of cardiovascular disease hospitalization in four low- and middle-income countries. PLoS One, 6, 2011, e20821.
14. Jan, S, Lee, SW, Sawhney, JP, et al. Catastrophic health expenditure on acute coronary events in Asia: a prospective study. Bull World Health Organ, 94, 2016, 193.
15. Ramachandran, R, Jha, V, Kidney transplantation is associated with catastrophic out of pocket expenditure in India. PLoS One, 8, 2013, e67812.
16. Bhojani, U, Thriveni, B, Devadasan, R, et al. Out-of-pocket healthcare payments on chronic conditions impoverish urban poor in Bangalore, India. BMC Public Health, 12, 2012, 990.
17. Dharmarajan, S, Phadnis, S, Gund, P, Kar, A, Out-of-pocket and catastrophic expenditure on treatment of haemophilia by Indian families. Haemophilia 20 (2014), 382–387.
18. Alvarez-Hernandez, E, Pelaez-Ballestas, I, Boonen, A, et al. Catastrophic health expenses and impoverishment of households of patients with rheumatoid arthritis. Reumatol Clin 8 (2012), 168–173.
19. Bhoo-Pathy, N, Yip, C-H, Peters, SAE, et al. Policy and priorities for national cancer control planning in low- and middle-income countries: lessons from the Association of Southeast Asian Nations (ASEAN) Costs in Oncology prospective cohort study. Eur J Cancer 74 (2017), 26–37.
20. Heeley, E, Anderson, CS, Huang, Y, et al. Role of health insurance in averting economic hardship in families after acute stroke in China. Stroke 40 (2009), 2149–2156.
21. Kavosi, Z, Delavari, H, Keshtkaran, A, Setoudehzadeh, F, Catastrophic health expenditures and coping strategies in households with cancer patients in Shiraz Namazi Hospital. Middle East J Cancer 5 (2014), 13–22.
22. Sun, Q, Liu, X, Meng, Q, Tang, S, Yu, B, Tolhurst, R, Evaluating the financial protection of patients with chronic disease by health insurance in rural China. Int J Equity Health, 8, 2009, 42.
23. Ughasoro, MD, Onwujekwe, OE, Ojinnaka, NC, Economic cost of treatment of childhood epilepsy in Enugu, southeast Nigeria. Int J Technol Assess Health Care 30 (2014), 469–474.
24. Xu, K, Evans, DB, Kawabata, K, Zeramdini, R, Klavus, J, Murray, CJ, Household catastrophic health expenditure: a multicountry analysis. Lancet 362 (2003), 111–117.
25. van Doorslaer, E, O'Donnell, O, Rannan-Eliya, RP, et al. Effect of payments for health care on poverty estimates in 11 countries in Asia: an analysis of household survey data. Lancet 368 (2006), 1357–1364.
26. Meng, Q, Xu, K, Progress and challenges of the rural cooperative medical scheme in China. Bull World Health Organ 92 (2014), 447–451.
27. Prakongsai, P, Palmer, N, Uay-Trakul, P, Tangcharoensathien, V, Mills, A, the implications of benefit package design: the impact on poor Thai households of excluding renal replacement therapy. J Int Dev 21 (2009), 291–308.
28. Laurence, YV, Griffiths, UK, Vassall, A, Costs to health services and the patient of treating tuberculosis: a systematic literature review. Pharmacoeconomics 33 (2015), 939–955.
29. Gilson, L, The lessons of user fee experience in Africa. Health Policy Plan 12 (1997), 273–285.
30. Agyepong, IA, Nagai, RA, “We charge them; otherwise we cannot run the hospital” front line workers, clients and health financing policy implementation gaps in Ghana. Health Policy 99 (2011), 226–233.
31. Lagarde, M, Palmer, N, The impact of user fees on access to health services in low- and middle-income countries. Cochrane Database Syst Rev, 4, 2011 CD009094.
32. James, CD, Hanson, K, McPake, B, et al. To retain or remove user fees? Reflections on the current debate in low-and middle-income countries. Appl Health Econ Health Policy 5 (2006), 137–153.
33. Barber, S, Bonnet, F, Bekedam, H, Formalizing under-the-table payments to control out-of-pocket hospital expenditures in Cambodia. Health Policy Plan 19 (2004), 199–208.
34. Bigdeli, M, Annear, PL, Barriers to access and the purchasing function of health equity funds: lessons from Cambodia. Bull World Health Organ 87 (2009), 560–564.
35. Flores, G, Ir, P, Men, CR, O'Donnell, O, van Doorslaer, E, Financial protection of patients through compensation of providers: the impact of Health Equity Funds in Cambodia. J Health Econ 32 (2013), 1180–1193.
36. Ir, P, Bigdeli, M, Meessen, B, Van Damme, W, Translating knowledge into policy and action to promote health equity: The Health Equity Fund policy process in Cambodia 2000-2008. Health Policy 96 (2010), 200–209.
37. Annear, PL, Wilkinson, D, Chean, MR, van Pelt, M, Penh, P, Study of financial access to health services for the poor in Cambodia. 2006, Cambodia Ministry of Health, WHO, AusAID, RMIT University, Phnom Penh.
38. Ahmed, S, Annear, PL, Phonvisay, B, et al. Institutional design and organizational practice for universal coverage in lesser-developed countries: challenges facing the Lao PDR. Soc Sci Med 96 (2013), 250–257.
39. Atun, R, Aydin, S, Chakraborty, S, et al. Universal health coverage in Turkey: enhancement of equity. Lancet 382 (2013), 65–99.
40. Knaul, FM, Gonzalez-Pier, E, Gomez-Dantes, O, et al. The quest for universal health coverage: achieving social protection for all in Mexico. Lancet 380 (2012), 1259–1279.
41. McIntyre, D, Ranson, MK, Aulakh, BK, Honda, A, Promoting universal financial protection: evidence from seven low- and middle-income countries on factors facilitating or hindering progress. Health Res Policy Syst, 11, 2013, 36.
42. Tangcharoensathien, V, Patcharanarumol, W, Ir, P, et al. Health-financing reforms in southeast Asia: challenges in achieving universal coverage. Lancet 377 (2011), 863–873.
43. World Health Organization. World health report 2000. Health systems: improving performance. 2000, World Health Organization, Geneva.
44. Giedion, U, Andrés Alfonso, E, Díaz, Y, The impact of universal coverage schemes in the developing world: a review of the existing evidence. 2013, World Bank, New York, NY.
45. Gwatkin, DR, Ergo, A, Universal health coverage: friend or foe of health equity?. Lancet 377 (2011), 2160–2161.
46. Jamison, DT, Summers, LH, Alleyne, G, et al. Global health 2035: a world converging within a generation. Lancet 382 (2013), 1898–1955.
47. Perera, M, Gunatilleke, G, Bird, P, Falling into the medical poverty trap in Sri Lanka: what can be done?. Int J Health Serv 37 (2007), 379–398.
48. Dmytraczenko, T, Almeida, G, Toward universal health coverage and equity in Latin America and the Caribbean: evidence from selected countries. 2015, World Bank, New York, NY.
49. Tantivess, S, Teerawattananon, Y, Mills, A, Strengthening cost-effectiveness analysis in Thailand through the establishment of the health intervention and technology assessment program. Pharmacoeconomics 27 (2009), 931–945.
50. Campbell, B, Morris, R, Mandava, L, et al. Identifying and selecting new procedures for health technology assessment: a decade of nice experience in the United Kingdom. Int J Technol Assess Health Care 30 (2014), 454–460.
51. Hailey, D, The history of health technology assessment in Australia. Int J Technol Assess Health Care 25:suppl 1 (2009), 61–67.
52. Chisholm, D, Baltussen, R, Evans, DB, What are the priorities for prevention and control of non-communicable diseases and injuries in sub-Saharan Africa and South East Asia?. BMJ, 344, 2012, e586.
53. Evans, DB, Edejer, TT-T, Adam, T, Lim, SS, Methods to assess the costs and health effects of interventions for improving health in developing countries. BMJ 331 (2005), 1137–1140.
54. Jamison, DT, Gelband, H, Horton, S, et al. Disease control priorities: improving health and reducing poverty. Jamison, DT, Gelband, H, Horton, S, et al. (eds.) Disease control priorities, 3rd edn., Volume 9, 2018, World Bank, Washington, DC.
55. WHO. World economic forum. From burden to “best buys”: reducing the economic impact of non-communicable diseases in low-and middle-income countries. 2011, World Health Organization, Geneva.
56. Gnjidic, D, Elshaug, AG, De-adoption and its 43 related terms: harmonizing low-value care terminology. BMC Med, 13, 2015, 273.
57. Chan, M, Making fair choices on the path to universal health coverage. Health Sys Ref 2 (2016), 5–7.
58. Schoen, C, Osborn, R, Squires, D, Doty, MM, Pierson, R, Applebaum, S, How health insurance design affects access to care and costs, by income, in eleven countries. Health Aff (Millwood) 29 (2010), 2323–2334.
59. Xu, K, Evans, DB, Carrin, G, Aguilar-Rivera, AM, Musgrove, P, Evans, T, Protecting households from catastrophic health spending. Health Aff 26 (2007), 972–983.
60. Tantivess, S, Werayingyong, P, Chuengsaman, P, Teerawattananon, Y, Universal coverage of renal dialysis in Thailand: promise, progress, and prospects. BMJ, 346, 2013, f462.
61. Jenkins, S, Wingate, C, Who cares for young carers?. BMJ 308 (1994), 733–734.
62. Evans, R, Becker, S, Hidden young carers: the experiences, needs and resilience of children caring for parents and relatives with HIV/AIDS in Tanzania and the UK. 2007, University of Nottingham, Nottingham.
63. Kuh, D, Power, C, Blane, D, Bartley, M, Socioeconomic pathways between childhood and adult health. Kuh, D, Ben-Schlomo, Y, (eds.) A life course approach to chronic disease epidemiology, 2004, Oxford University Press, Oxford.
64. Schmidt, H, Gostin, LO, Emanuel, EJ, Public health, universal health coverage, and Sustainable Development Goals: can they coexist?. Lancet 386 (2015), 928–930.
65. Waage, J, Yap, C, Bell, S, et al. Governing the UN Sustainable Development Goals: interactions, infrastructures, and institutions. Lancet Glob Health 3 (2015), e251–e252.
66. Fevia, FF, The role that civil society can play in ensuring accountability in social protection programmes. http://socialprotection-humanrights.org/expertcom/the-role-that-civil-society-can-play-in-ensuring-accountability-in-social-protection-programmes/, 2014 (accessed June 27, 2016).
67. McIntyre, D, What healthcare financing changes are needed to reach universal coverage in South Africa?. S Afr Med J 102 (2012), 489–490.
68. McIntyre, D, Garshong, B, Mtei, G, et al. Beyond fragmentation and towards universal coverage: insights from Ghana, South Africa and the United Republic of Tanzania. Bull World Health Organ 86 (2008), 871–876.
69. Chow, CK, Teo, KK, Rangarajan, S, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 310 (2013), 959–968.
70. Leatherman, S, Dunford, C, Linking health to microfinance to reduce poverty. Bull World Health Organ 88 (2010), 470–471.
71. Pronyk, PM, Hargreaves, JR, Kim, JC, et al. Effect of a structural intervention for the prevention of intimate-partner violence and HIV in rural South Africa: a cluster randomised trial. Lancet 368 (2006), 1973–1983.
72. Lagarde, M, Haines, A, Palmer, N, Conditional cash transfers for improving uptake of health interventions in low- and middle-income countries: a systematic review. JAMA 298 (2007), 1900–1910.
73. Lagarde, M, Haines, A, Palmer, N, The impact of conditional cash transfers on health outcomes and use of health services in low and middle income countries. Cochrane Database Syst Rev, 4, 2009 CD008137.
74. Robertson, L, Mushati, P, Eaton, JW, et al. Effects of unconditional and conditional cash transfers on child health and development in Zimbabwe: a cluster-randomised trial. The Lancet 381 (2013), 1283–1292.
75. Jan, S, Ferrari, G, Watts, CH, et al. Economic evaluation of a combined microfinance and gender training intervention for the prevention of intimate partner violence in rural South Africa. Health Policy Plan 26 (2011), 366–372.
76. Ranganathan, M, Lagarde, M, Promoting healthy behaviours and improving health outcomes in low and middle income countries: a review of the impact of conditional cash transfer programmes. Prev Med 55:suppl (2012), S95–S105.
77. Arnold, C, Conway, T, Greenslade, M, DFID cash transfers literature review. 2011, Department for International Development, London.
78. Bautista, LE, Vera-Cala, LM, Ferrante, D, et al. A ‘polypill’ aimed at preventing cardiovascular disease could prove highly cost-effective for use in Latin America. Health Aff (Project Hope) 32 (2013), 155–164.
79. Huffman, MD, Yusuf, S, Polypills: essential medicines for cardiovascular disease secondary prevention?. J Am Coll Cardiol 63 (2014), 1368–1370.
80. Reardon, S, Public health. Experts debate polypill: a single pill for global health. Science, 333, 2011, 1813.
81. Sanz, G, Fuster, V, Polypill and global cardiovascular health strategies. Semin Thorac Cardiovasc Surg 23 (2011), 24–29.
82. Joshi, R, Alim, M, Kengne, AP, et al. Task shifting for non-communicable disease management in low and middle income countries—a systematic review. PLoS One, 9, 2014, e103754.
83. Howitt, P, Darzi, A, Yang, GZ, et al. Technologies for global health. Lancet 380 (2012), 507–535.
84. Atun, R, Jaffar, S, Nishtar, S, et al. Improving responsiveness of health systems to non-communicable diseases. Lancet 381 (2013), 690–7607.
85. Peiris, D, Praveen, D, Johnson, C, Mogulluru, K, Use of mHealth systems and tools for non-communicable diseases in low- and middle-income countries: a systematic review. J Cardiovasc Transl Res 7 (2014), 677–691.
86. Grimsrud, A, Sharp, J, Kalombo, C, Bekker, LG, Myer, L, Implementation of community-based adherence clubs for stable antiretroviral therapy patients in Cape Town, South Africa. J Int AIDS Soc, 18, 2015, 19984.
87. Asaria, P, Chisholm, D, Mathers, C, Ezzati, M, Beaglehole, R, Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet 370 (2007), 2044–2053.
88. Verguet, S, Gauvreau, CL, Mishra, S, et al. The consequences of tobacco tax on household health and finances in rich and poor smokers in China: an extended cost-effectiveness analysis. Lancet Global Health 3 (2015), e206–e216.
89. Sassi, F, Belloni, A, Mirelman, A, et al. Equity impacts of price policies to promote healthy behaviours. Lancet, 2018 published online April 4. http://dx.doi.org/10.1016/S0140-6736(18)30531-2.
90. Boerma, T, Eozenou, P, Evans, D, Evans, T, Kieny, M-P, Wagstaff, A, Monitoring progress towards universal health coverage at country and global levels. PLoS Med, 11, 2014, e1001731.
91. Ruger, JP, An alternative framework for analyzing financial protection in health. PLoS Med, 9, 2012, e1001294.
92. Moreno-Serra, R, Millett, C, Smith, PC, Towards improved measurement of financial protection in health. PLoS Med, 8, 2011, e1001087.
93. McIntyre, D, Ataguba, JE, How to do (or not to do) … a benefit incidence analysis. Health Policy Plan 26 (2011), 174–182.
94. Wiseman V, Asante A, Price J, et al. Ten best resources for conducting financing and benefit incidence analysis in resource-poor settings. Health Policy Plan; 30: 1053–58.
95. Swanson, RC, Atun, R, Best, A, et al. Strengthening health systems in low-income countries by enhancing organizational capacities and improving institutions. Global Health, 1, 2015, 5.
96. Hamid, SA, Ahsan, SM, Begum, A, Disease-specific impoverishment impact of out-of-pocket payments for health care: evidence from rural Bangladesh. Appl Health Econ Health Policy 12 (2014), 421–433.
97. Patel, V, Chisholm, D, Kirkwood, BR, Mabey, D, Prioritizing health problems in women in developing countries: comparing the financial burden of reproductive tract infections, anaemia and depressive disorders in a community survey in India. Trop Med Int Health 12 (2007), 130–139.
98. Sadoh, WE, Nwaneri, DU, Owobu, AC, The cost of out-patient management of chronic heart failure in children with congenital heart disease. Niger J Clin Pract 14 (2011), 65–69.
99. Saito, E, Gilmour, S, Rahman, MM, Gautam, GS, Shrestha, PK, Shibuya, K, Catastrophic household expenditure on health in Nepal: a cross-sectional survey. Bull World Health Organ 92 (2014), 760–767.
100. Essue, BM, Li, Q, Hackett, ML, Keay, L, Iezzi, B, Tran, KD, Tan Phuc, H, Jan, S, A multicenter prospective cohort study of quality of life and economic outcomes after cataract surgery in Vietnam: the VISIONARY study. Ophthalmology 121 (2014), 2138–2146.
101. Kimman, M, Jan, S, Yip, CH, et al. Catastrophic health expenditure and 12-month mortality associated with cancer in Southeast Asia: results from a longitudinal study in eight countries. BMC Med, 13, 2015, 190.
102. Rocha-Garcia, A, Hernandez-Pena, P, Ruiz-Velazco, S, Avila-Burgos, L, Marin-Palomares, T, Lazcano-Ponce, E, Out-of-pocket expenditures during hospitalization of young leukemia patients with state medical insurance in two Mexican hospitals. Salud Publica de Mexico 45 (2003), 285–292.
103. Gwatidzo, SD, Stewart Williams, J, Diabetes mellitus medication use and catastrophic healthcare expenditure among adults aged 50+ years in China and India: results from the WHO study on global AGEing and adult health (SAGE). BMC Geriatrics, 17, 2017, 14.
104. Zhao, T, Cheng, J, Chai, J, Feng, R, Liang, H, Shen, X, et al. Inpatient care burden due to cancers in Anhui, China: a cross-sectional household survey. BMC Public Health, 16, 2016, 308.
105. Daivadanam, M, Thankappan, KR, Sarma, PS, Harikrishnan, S, Catastrophic health expenditure & coping strategies associated with acute coronary syndrome in Kerala, India. Indian J Med Res 136 (2012), 585–592.
106. Janssens, W, Goedecke, J, Bree, GJD, Aderibigbe, SA, Akande, TM, Mesnard, A, The financial burden of non-communicable chronic diseases in rural Nigeria: Wealth and gender heterogeneity in health care utilization and health expenditures. PLoS ONE, 11, 2016, e0166121.
107. Kien, VD, Van Minh, H, Giang, KB, Dao, A, Tuan, LT, Ng, N, Socioeconomic inequalities in catastrophic health expenditure and impoverishment associated with non-communicable diseases in urban Hanoi, Vietnam. Int J Equity Health, 15, 2016, 169.
108. Murphy, A, Mahal, A, Richardson, E, Moran, AE, The economic burden of chronic disease care faced by households in Ukraine: a cross-sectional matching study of angina patients. Int J Equity Health, 12, 2013, 38.
109. Si, Y, Zhou, Z, Su, M, Ma, M, Xu, Y, Heitner, J, Catastrophic healthcare expenditure and its inequality for households with hypertension: Evidence from the rural areas of Shaanxi Province in China. Int J Equity Health, 16, 2017, 27.
110. Sun, J, Liabsuetrakul, T, Fan, Y, McNeil, E, Protecting patients with cardiovascular diseases from catastrophic health expenditure and impoverishment by health finance reform. Trop Med Int Health 20 (2015), 1846–1854.
111. Van Minh, H, Phuong, TH, Saksena, P, Assessment of financial protection in the Viet Nam health system: analysis of Vietnam living standard survey data 2002–2010. 2012, World Health Organization, Geneva.
112. Wang, Q, Liu, H, Lu, ZX, Luo, Q, Liu, JA, Role of the new rural cooperative medical system in alleviating catastrophic medical payments for hypertension, stroke and coronary heart disease in poor rural areas of China. BMC Public Health, 14, 2014, 907.
113. Liu, X, Sun, X, Zhao, Y, Meng, Q, Financial protection of rural health insurance for patients with hypertension and diabetes: repeated cross-sectional surveys in rural China. BMC Health Serv Res, 16, 2016, 481.
114. Okoronkwo, IL, Ekpemiro, JN, Okwor, EU, Okpala, PU, Adeyemo, FO, Economic burden and catastrophic cost among people living with type2 diabetes mellitus attending a tertiary health institution in south-east zone, Nigeria. BMC Res Notes, 8, 2015, 527.
115. Sukeri, S, Mirzaei, M, Jan, S, Does tax-based health financing offer protection from financial catastrophe? Findings from a household economic impact survey of ischaemic heart disease in Malaysia. Int Health 9 (2017), 29–35.
116. Wang, Z, Li, X, Chen, M, Catastrophic health expenditures and its inequality in elderly households with chronic disease patients in China. Int J Equity Health, 14, 2015, 8.